In memory of Sukhin Garry Markovich, a researcher at the P. Hertsen Moscow Oncology Research Institute

On October 28, 2024, at the age of 89, Garry Markovich Sukhin, a researcher at the P. Hertsen Moscow Oncology Research Institute and a candidate of medical sciences who made a significant contribution to the advancement of experimental research in medicine, passed away.

Garry Markovich Sukhin began his professional journey after graduating from the First Moscow Medical Institute. He was assigned to the P. Hertsen Institute, continuing the legacy of his father, Mark Yakovlevich Sukhin, who studied antitumor immunity under the guidance of N. F. Gamaleya. Garry Markovich’s scientific work in the Department of Experimental Tumor Therapy made a profound impact on the field of medicine in the Soviet Union and Russia. His studies on the antitumor activity of medications, efforts to reduce chemotherapy toxicity, experiments on bone marrow transplantation following toxic doses of chemotherapy, and numerous long-term studies on photosensitizers laid the foundation for the clinical application of photodynamic therapy for tumors.

Garry Markovich continued his professional activities by researching hematopoietic stem cells and contributed to the creation of the first state umbilical cord blood bank in 2003, where he headed a department at the State Institution “Stem Cell Bank” of the Moscow Department of Health.

Garry Markovich Sukhin was awarded the honorary badge “Excellence in Healthcare” and the “Veteran of Labor” medal.

Garry Markovich’s children have continued the family tradition in medicine. His son, Dmitry Garryevich, works in the Endoscopy Department of the P. Hertsen Moscow Oncology Research Institute, and his daughter, Natalya Garriyevna, is a gynecologist in a Moscow clinic.

The memory of Garry Markovich Sukhin will live on in the hearts of all who had the privilege of knowing and working with him.

P. Hertsen Moscow Oncology Research Institute